Time to ART initiation among patients treated for rifampicin-resistant tuberculosis in Khayelitsha, South Africa
This study examines impact on mortality and treatment success
Abstract
Setting
Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection.
Objective
To describe time to antiretroviral treatment (ART) initiation among HIV-infected RR-TB patients initiating RR-TB treatment and to assess the association between time to ART initiation and treatment outcomes.
Design
A retrospective cohort study of patients with RR-TB and HIV co-infection not on ART at RR-TB treatment initiation.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Daniels JF, Khogali M, Mohr E, Cox V, Moyo S, Edginton M, et al. (2015) Time to ART Initiation among Patients Treated for RifampicinResistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success. PLoS ONE 10(11): doi:10.1371/journalpone.0142873